WHITEOAK CAPITAL PHARMA AND HEALTHCARE FUND - REGULAR PLAN - GROWTH

Thematic • Very High Risk

WHITEOAK CAPITAL PHARMA AND HEALTHCARE FUND - REGULAR PLAN - GROWTH

Category: Thematic

CRISIL Rating: Very High Risk

Code: YE110G-GR

NAV

₹13.70

0.15 (1.10%)
2026-02-20
Fund Rating

3 ⭐

Fund Information
Fund Size (AUM): 49.18 CR
Fund Strategy: Very High Risk
Expense Ratio: 2.3800%
Fund Manager:
Min Lump Sum: ₹500.00
Min SIP: ₹100.00
ISIN: INF03VN01878
Benchmark:
0.00% 3Y annualised
NAV

₹13.70

2026-02-20
Fund Rating

3 ⭐

Fund Size

49.18 CR

Fund Strategy

Very High Risk

₹500 ₹100,000
Total Investment: ₹15,000
Total Value: ₹0
Login to Invest

Login to create portfolios and start investing

Sector Allocation
Top Holdings
Security Name Weight (%)
Max Healthcare Institute Ltd Ordinary Shares 7.97%
Sun Pharmaceuticals Industries Ltd 7.32%
Divi's Laboratories Ltd 7.09%
Fortis Healthcare Ltd 5.56%
Cipla Ltd 5.21%
Laurus Labs Ltd 4.14%
Krishna Institute of Medical Sciences Ltd 3.91%
Torrent Pharmaceuticals Ltd 3.72%
Clearing Corporation Of India Ltd 3.53%
Lupin Ltd 3.28%

Fund Rating

3 out of 5

Funds in Same Category

No other funds found in this category.